© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Senseonics Holdings, Inc. (SENS) stock declined over -1.03%, trading at $0.97 on AMEX, down from the previous close of $0.98. The stock opened at $0.98, fluctuating between $0.93 and $0.98 in the recent session.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Employees | 132 |
Beta | 0.8 |
Sales or Revenue | $22.39M |
5Y Sales Change% | -0.672% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Senseonics Holdings, Inc. (AMEX: SENS) stock price is $0.97 in the last trading session. During the trading session, SENS stock reached the peak price of $0.98 while $0.93 was the lowest point it dropped to. The percentage change in SENS stock occurred in the recent session was -1.03% while the dollar amount for the price change in SENS stock was -$0.01.
The AMEX listed SENS is part of Medical - Devices industry that operates in the broader Healthcare sector. Senseonics Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Kenneth L. Horton
Gen. Counsel & Corporation Devel. Advisor
Dr. Timothy T. Goodnow
Pres, Chief Executive Officer & Director
Mr. Frederick T. Sullivan
Chief Financial Officer, Sec. & Treasurer
Dr. Timothy T. Goodnow Ph.D.
Pres, Chief Executive Officer & Director
Dr. Francine Ratner Kaufman M.D.
Chief Medical Officer & Director
Dr. Mukul Jain
Chief Operating Officer
SENS's closing price is 292.04% higher than its 52-week low of $0.25 where as its distance from 52-week high of $1.04 is -5.76%.
Number of SENS employees currently stands at 132.
Official Website of SENS is: https://www.senseonics.com
SENS could be contacted at phone 301 515 7260 and can also be accessed through its website. SENS operates from 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, United States.
SENS stock volume for the day was 4.05M shares. The average number of SENS shares traded daily for last 3 months was 12.45M.
The market value of SENS currently stands at $577.47M with its latest stock price at $0.97 and 595.33M of its shares outstanding.